NCT01261286View on ClinicalTrials.gov

Drug-Disease Interaction in Crohn's Disease

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Crohn's Disease

Interventions

DRUG

verapamil

Trial Locations (1)

T6G-2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER

NCT01261286 - Drug-Disease Interaction in Crohn's Disease | Biotech Hunter | Biotech Hunter